Core Insights - Catheter Precision, Inc. has received its first purchase order from Dubrava Hospital in Croatia after winning a competitive tender bid, marking a significant milestone for the company in expanding its market presence in Europe [1][2][3] Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for the treatment of cardiac arrhythmias, particularly in the electrophysiology market [4] - The company collaborates with physicians to continuously advance its products and improve patient care [4] Product Details - The VIVO (View Into Ventricular Onset) system is a non-invasive 3D imaging technology that helps physicians identify the origin of ventricular arrhythmias before procedures, thereby enhancing workflow and reducing procedure time [3] - VIVO has received marketing clearance from the U.S. FDA and holds the CE Mark, indicating its compliance with European health standards [3] Hospital Evaluation - Dubrava University Hospital, a leading hospital in Croatia, evaluated the VIVO system before including it in the bidding process, highlighting its simple and flexible workflow and the accuracy of its mapping capabilities [2] - The hospital treats over 25,000 inpatients annually and provides more than 1,500,000 health services to over 400,000 outpatients, indicating a substantial potential market for Catheter Precision's products [2] Market Expansion - The purchase order from Dubrava Hospital reflects the growing trust and enthusiasm among leading clinicians in Europe for Catheter Precision's technologies, suggesting potential for continued growth in the region [3]
Catheter Precision Announces Tender Win and First Purchase Order in Croatia